← Browse by Condition
Medical Condition
osteosarcoma
Total Trials
11
Recruiting Now
11
Trial Phases
EARLY_Phase 1, Phase 1, Phase 2, Phase 2
ClinicalMetric tracks all active clinical trials for osteosarcoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — osteosarcoma Clinical Trials
How many clinical trials are currently recruiting for osteosarcoma?
ClinicalMetric currently tracks 11 actively recruiting clinical trials for osteosarcoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 11. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for osteosarcoma?
osteosarcoma research spans Phase 1 (7 trials), Phase 2 (4 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a osteosarcoma clinical trial?
Eligibility criteria for osteosarcoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 7
Phase 2 4
Top Sponsors
2 trials
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06645808 EARLY_Phase 1
Recruiting
Enrollment
32 pts
Location
Netherlands
Sponsor
Var2 Pharmaceuticals
NCT07479732 Phase 1, Phase 2
Recruiting
Enrollment
56 pts
Location
China
Sponsor
Peking University People's Hos...
NCT04040205 Phase 2
Recruiting
Enrollment
44 pts
Location
United States
Sponsor
Medical College of Wisconsin
NCT05492682 Phase 1
Recruiting
Enrollment
15 pts
Location
Germany, Italy
Sponsor
Valo Therapeutics Oy
NCT07052383 Phase 1
Recruiting
Enrollment
15 pts
Location
China
Sponsor
Tcelltech Inc.
NCT06778603 Phase 1, Phase 2
Recruiting
Enrollment
32 pts
Location
China
Sponsor
Peking University People's Hos...
NCT05062707
Recruiting
Enrollment
120 pts
Location
Netherlands
Sponsor
University Medical Center Gron...
NCT01790152
Recruiting
Enrollment
420 pts
Location
United States, Austr...
Sponsor
Children's Oncology Group
NCT04897321 Phase 1
Recruiting
Enrollment
48 pts
Location
United States
Sponsor
St. Jude Children's Research H...
NCT05227326 Phase 1
Recruiting
Enrollment
92 pts
Location
United States
Sponsor
City of Hope Medical Center
NCT04698785 Phase 2
Recruiting
Enrollment
36 pts
Location
France
Sponsor
Centre Leon Berard
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology